[1]
|
中华医学会心血管病学分会心力衰竭学组, 中国医师协会心力衰竭专业委员会, 中华心血管病杂志编辑委员会. 中国心力衰竭诊断和治疗指南2018[J]. 中华心血管病杂志, 2018, 46(10): 760-789.
|
[2]
|
Bell, D.S.H. and Gon-calves, E. (2019) Heart Failure in the Patient with Diabetes: Epidemiology, Aetiology, Prognosis, Therapy and the Effect of Glucose-Lowering Medications. Diabetes, Obesity & Metabolism, 21, 1277-1290.
https://doi.org/10.1111/dom.13652
|
[3]
|
Koniari, I., Velissaris, D., Kounis, N.G., et al. (2022) Anti-Diabetic Ther-apy, Heart Failure and Oxidative Stress: An Update. Journal of Clinical Medicine, 11, Article 4660. https://doi.org/10.3390/jcm11164660
|
[4]
|
Dunlay, S.M., Killian, J.M., McCoy, R.G. and Redfield, M.M. (2022) Diabetes Mellitus in Advanced Heart Failure. Journal of Cardiac Failure, 28, 503-508. https://doi.org/10.1016/j.cardfail.2021.09.016
|
[5]
|
Pazin-Filho, A., Kottgen, A., Bertoni, A.G., et al. (2008) HbA 1c as a Risk Factor for Heart Failure in Persons with Diabetes: The Atherosclerosis Risk in Communities (ARIC) Study. Diabetologia, 51, 2197-2204.
https://doi.org/10.1007/s00125-008-1164-z
|
[6]
|
Roth, G.A., Mensah, G.A., Johnson, C.O., et al. (2020) Global Burden of Cardiovascular Diseases and Risk Factors, 1990-2019: Update from the GBD 2019 Study. Journal of the American College of Cardiology, 76, 2982-23021.
https://doi.org/10.1016/j.jacc.2020.11.010
|
[7]
|
中国心血管健康与疾病报告编写组. 中国心血管健康与疾病报告2020概要[J]. 中国循环杂志, 2021, 36(6): 521-545.
|
[8]
|
中国心衰中心联盟, 苏州工业园区心血管健康研究院, 中国心血管健康联盟. 中国心衰中心工作报告(2021)——心力衰竭患者的诊疗现况[J]. 中国介入心脏病学杂志, 2022, 30(5): 328-336.
|
[9]
|
Sun, H., Saeedi, P., Karuranga, S., et al. (2022) IDF Diabetes Atlas: Global, Regional and Country-Level Diabetes Prevalence Estimates for 2021 and Projections for 2045. Diabetes Research and Clinical Prac-tice, 183, Article ID: 109119. https://doi.org/10.1016/j.diabres.2021.109119
|
[10]
|
He, J., Ogden, L.G., Bazzano, L.A., et al. (2001) Risk Factors for Congestive Heart Failure in US Men and Women: NHANES I Epidemiologic Fol-low-Up Study. Archives of Internal Medicine, 161, 996-1002.
https://doi.org/10.1001/archinte.161.7.996
|
[11]
|
Seferović, P.M., Petrie, M.C., Filippatos, G.S., et al. (2018) Type 2 Diabetes Mellitus and Heart Failure: A Position Statement from the Heart Failure Association of the European Society of Cardiology. European Journal of Heart Failure, 20, 853-872. https://doi.org/10.1002/ejhf.1170
|
[12]
|
Kannel, W.B., Hjortland, M. and Castelli, W.P. (1974) Role of Diabetes in Congestive Heart Failure: The Framingham Study. The American Journal of Cardiology, 34, 29-34. https://doi.org/10.1016/0002-9149(74)90089-7
|
[13]
|
Park, J.J. (2021) Epidemiology, Pathophysiology, Diagnosis and Treatment of Heart Failure in Diabetes. Diabetes & Metabolism Journal, 45, 146-157. https://doi.org/10.4093/dmj.2020.0282
|
[14]
|
Sarma, S., Mentz, R.J., Kwasny, M.J., et al. (2013) As-sociation between Diabetes Mellitus and Post-Discharge Outcomes in Patients Hospitalized with Heart Failure: Findings from the EVEREST Trial. European Journal of Heart Failure, 15, 194-202. https://doi.org/10.1093/eurjhf/hfs153
|
[15]
|
Zhang, Y., Zhang, J., Butler, J., et al. (2017) Contemporary Epidemiol-ogy, Management, and Outcomes of Patients Hospitalized for Heart Failure in China: Results from the China Heart Fail-ure (China-HF) Registry. Journal of Cardiac Failure, 23, 868-875. https://doi.org/10.1016/j.cardfail.2017.09.014
|
[16]
|
Nakamura, K., Miyoshi, T., Yoshida, M., et al. (2022) Patho-physiology and Treatment of Diabetic Cardiomyopathy and Heart Failure in Patients with Diabetes Mellitus. International Journal of Molecular Sciences, 23, Article 3587.
https://doi.org/10.3390/ijms23073587
|
[17]
|
Rubler, S., Dlugash, J., Yuceoglu, Y.Z., et al. (1972) New Type of Cardiomyopathy Associated with Diabetic Glomerulosclerosis. The American Journal of Cardiology, 30, 595-602. https://doi.org/10.1016/0002-9149(72)90595-4
|
[18]
|
Connelly, K.A., Kelly, D.J., Zhang, Y., et al. (2007) Function-al, Structural and Molecular Aspects of Diastolic Heart Failure in the Diabetic (mRen-2)27 Rat. Cardiovascular Research, 76, 280-291.
https://doi.org/10.1016/j.cardiores.2007.06.022
|
[19]
|
Lebeche, D., Davidoff, A.J. and Hajjar, R.J. (2008) Interplay between Impaired Calcium Regulation and Insulin Signaling Abnormalities in Diabetic Cardiomyopathy. Nature Clinical Practice Cardiovascular Medicine, 5, 715-724.
https://doi.org/10.1038/ncpcardio1347
|
[20]
|
Huynh, K., Kiriazis, H., Du, X.J., et al. (2012) Coenzyme Q10 Attenu-ates Diastolic Dysfunction, Cardiomyocyte Hypertrophy and Cardiac Fibrosis in the db/db Mouse Model of Type 2 Dia-betes. Diabetologia, 55, 1544-1553.
https://doi.org/10.1007/s00125-012-2495-3
|
[21]
|
Bugger, H. and Abel, E.D. (2014) Molecular Mechanisms of Di-abetic Cardiomyopathy. Diabetologia, 57, 660-671.
https://doi.org/10.1007/s00125-014-3171-6
|
[22]
|
Huynh, K., Bernardo, B.C., McMullen, J.R., et al. (2014) Diabetic Cardiomyopathy: Mechanisms and New Treatment Strategies Targeting Antioxidant Signaling Pathways. Pharmacology & Therapeutics, 142, 375-415.
https://doi.org/10.1016/j.pharmthera.2014.01.003
|
[23]
|
American Diabetes Association (2010) Standards of Medical Care in Diabetes—2010. Diabetes Care, 33, S11-S61.
https://doi.org/10.2337/dc10-S011
|
[24]
|
American Diabetes Association (2010) Diagnosis and Classification of Diabetes Mellitus. Diabetes Care, 33, S62-S69.
https://doi.org/10.2337/dc10-S062
|
[25]
|
Selvin, E., Marinopoulos, S., Berkenblit, G., et al. (2004) Meta-Analysis: Glycosylated Hemoglobin and Cardiovascular Disease in Diabetes Mellitus. Annals of Internal Medicine, 141, 421-431.
https://doi.org/10.7326/0003-4819-141-6-200409210-00007
|
[26]
|
Shi, C., Wang, L.J., Hu, D.F., et al. (2010) Prevalence, Clinical Characteristics and Outcome in Patients with Chronic Heart Failure and Diabetes. Chinese Medical Journal, 123, 646-650.
https://doi.org/10.3760/cma.j.issn.0366-6999.2010.06.002
|
[27]
|
陈春晓, 蔡丽蓉, 魏贤聪. 慢性心衰合并2型糖尿病患者HbA1c水平与心衰严重程度的相关性研究[J]. 黑龙江医药, 2021, 34(1): 14-17.
|
[28]
|
Stratton, I.M., Adler, A.I., Neil, H.A., et al. (2000) Association of Glycaemia with Macrovascular and Microvascular Complications of Type 2 Diabetes (UKPDS 35): Prospective Observational Study. BMJ, 321, 405-412.
https://doi.org/10.1136/bmj.321.7258.405
|
[29]
|
Aguilar, D., Bozkurt, B., Ramasubbu, K., et al. (2009) Relationship of Hemoglobin A1C and Mortality in Heart Failure Patients with Diabetes. Journal of the American College of Cardiol-ogy, 54, 422-428.
https://doi.org/10.1016/j.jacc.2009.04.049
|
[30]
|
Gerstein, H.C., Miller, M.E., Byington, R.P., et al. (2008) Effects of Intensive Glucose Lowering in Type 2 Diabetes. The New England Journal of Medicine, 358, 2545-2559. https://doi.org/10.1056/NEJMoa0802743
|
[31]
|
Eshaghian, S., Horwich, T.B. and Fonarow, G.C. (2006) An Unex-pected Inverse Relationship between HbA1c Levels and Mortality in Patients with Diabetes and Advanced Systolic Heart Failure. American Heart Journal, 151, 91.e1-91.e6. https://doi.org/10.1016/j.ahj.2005.10.008
|
[32]
|
Blecker, S., Park, H. and Katz, S.D. (2016) Association of HbA1c with Hospitalization and Mortality among Patients with Heart Failure and Diabetes. BMC Cardiovascular Disorders, 16, Article No. 99.
https://doi.org/10.1186/s12872-016-0275-6
|
[33]
|
Gerstein, H.C., Swedberg, K., Carlsson, J., et al. (2008) The He-moglobin A1c Level as a Progressive Risk Factor for Cardiovascular Death, Hospitalization for Heart Failure, or Death in Patients with Chronic Heart Failure: An Analysis of the Candesartan in Heart Failure: Assessment of Reduction in Mor-tality and Morbidity (CHARM) Program. Archives of Internal Medicine, 168, 1699-1704. https://doi.org/10.1001/archinte.168.15.1699
|
[34]
|
Parry, H.M., Deshmukh, H., Levin, D., et al. (2015) Both High and Low HbA1c Predict Incident Heart Failure in Type 2 Diabetes Mellitus. Circulation Heart failure, 8, 236-242.
https://doi.org/10.1161/CIRCHEARTFAILURE.113.000920
|
[35]
|
Gu, J., Pan, J.A., Fan, Y.Q., et al. (2018) Prognostic Impact of HbA1c Variability on Long-Term Outcomes in Patients with Heart Failure and Type 2 Diabetes Mellitus. Cardiovascular Diabetology, 17, Article No. 96.
https://doi.org/10.1186/s12933-018-0739-3
|
[36]
|
Segar, M.W., Patel, K.V., Vaduganathan, M., et al. (2020) Asso-ciation of Long-Term Change and Variability in Glycemia with Risk of Incident Heart Failure among Patients with Type 2 Diabetes: A Secondary Analysis of the ACCORD Trial. Diabetes Care, 43, 1920-1928. https://doi.org/10.2337/dc19-2541
|
[37]
|
Wang, P., Huang, R., Lu, S., et al. (2015) HbA1c below 7% as the Goal of Glucose Control Fails to Maximize the Cardiovascular Benefits: A Meta-Analysis. Cardiovascular Diabetology, 14, Ar-ticle No. 124.
https://doi.org/10.1186/s12933-015-0285-1
|
[38]
|
Bahtiyar, G., Gutterman, D. and Lebovitz, H. (2016) Heart Failure: A Major Cardiovascular Complication of Diabetes Mellitus. Current Diabetes Reports, 16, 116. https://doi.org/10.1007/s11892-016-0809-4
|
[39]
|
中华医学会内分泌学分会. 中国成人2型糖尿病合并心肾疾病患者降糖药物临床应用专家共识[J]. 中华糖尿病杂志, 2020, 12(6): 369-381.
|